SCHEMBL6585212

SCHEMBL6585212

COc1ccc2c(Cc3c(Cl)cncc3Cl)nnc(N3CCOCC3)c2c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 14/20 1.00
PDE4B Q07343 14/20 1.00
PDE4C Q08493 14/20 1.00
PDE4D Q08499 14/20 1.00
HPGD P15428 3/20 0.46
KDM4E B2RXH2 2/20 0.40
ALDH1A1 P00352 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2C19 P33261 1/20 0.40
NPC1 O15118 1/20 0.40
GLA P06280 1/20 0.40
GAA P10253 1/20 0.40
RAB9A P51151 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
CDK1 P06493 2/20 0.40
IGF1R P08069 2/20 0.40
FGFR1 P11362 2/20 0.40
BRAF P15056 2/20 0.40
FGFR2 P21802 2/20 0.40
FGFR4 P22455 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6586051 0.91 PDE4A (1.00) PDE4APDE4BPDE4CPDE4DSMN1; SMN2
SCHEMBL6587035 0.89 PDE4A (0.84) PDE4APDE4BPDE4CPDE4DCDK1
SCHEMBL6585132 0.87 PDE4A (0.77) PDE4APDE4BPDE4CPDE4DHPGD
SCHEMBL6587944 0.87 PDE4A (0.76) PDE4APDE4BPDE4CPDE4DKDM4E
SCHEMBL6588373 0.81 PDE4A (0.72) PDE4APDE4BPDE4CPDE4D
SCHEMBL6589638 0.80 PDE4A (0.67) PDE4APDE4BPDE4CPDE4DSMN1; SMN2
SCHEMBL6588133 0.79 PDE4A (0.75) PDE4APDE4BPDE4CPDE4DKDM4E
SCHEMBL6589078 0.79 PDE4A (0.72) PDE4APDE4BPDE4CPDE4D
SCHEMBL6587900 0.79 PDE4A (0.72) PDE4APDE4BPDE4CPDE4D
SCHEMBL6589991 0.79 PDE4A (0.72) PDE4APDE4BPDE4CPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1097142-B1 PHTHALAZINE DERIVATIVES PHOSPHODIESTERASE 4 INHIBITORS ZAMBON SPA (IT) 2004-10-13 EP claimed
US-6329370-B1 CARDIOVASCULAR DISORDERS AND TUMOR NECROSIS FACTOR (HEREINAFTER TNF.SUB..ALPHA.), A CYTOKINE WITH PRO-INFLAMMATORY ACTIVITY ZAMBON GROUP S.P.A. (IT) 2001-12-11 US claimed
EP-1097142-A1 PHTHALAZINE DERIVATIVES PHOSPHODIESTERASE 4 INHIBITORS ZAMBON GROUP S.p.A. (IT) 2001-05-09 EP claimed
WO-2000005218-A1 PHTHALAZINE DERIVATIVES PHOSPHODIESTERASE 4 INHIBITORS ZAMBON GROUP S.P.A. (IT) 2000-02-03 WO claimed
EP-1097142-B1 PHTHALAZINE DERIVATIVES PHOSPHODIESTERASE 4 INHIBITORS ZAMBON SPA (IT) 2004-10-13 EP disclosed
US-6492360-B1 Phthalazine derivatives phosphodiesterase 4 inhibitors ZAMBON GROUP S.P.A. (IT) 2002-12-10 US disclosed
US-6329370-B1 CARDIOVASCULAR DISORDERS AND TUMOR NECROSIS FACTOR (HEREINAFTER TNF.SUB..ALPHA.), A CYTOKINE WITH PRO-INFLAMMATORY ACTIVITY ZAMBON GROUP S.P.A. (IT) 2001-12-11 US disclosed
US-6329370-B1 CARDIOVASCULAR DISORDERS AND TUMOR NECROSIS FACTOR (HEREINAFTER TNF.SUB..ALPHA.), A CYTOKINE WITH PRO-INFLAMMATORY ACTIVITY ZAMBON GROUP S.P.A. (IT) 2001-12-11 US disclosed
EP-1097142-A1 PHTHALAZINE DERIVATIVES PHOSPHODIESTERASE 4 INHIBITORS ZAMBON GROUP S.p.A. (IT) 2001-05-09 EP disclosed
WO-2000005218-A1 PHTHALAZINE DERIVATIVES PHOSPHODIESTERASE 4 INHIBITORS ZAMBON GROUP S.P.A. (IT) 2000-02-03 WO disclosed